Gregory S Hageman

Title: Innovations by Gregory S Hageman

Introduction

Gregory S Hageman is a notable inventor based in Coralville, IA (US), recognized for his significant contributions to the field of medical research, particularly in the treatment of age-related macular degeneration (AMD). With a total of 13 patents to his name, Hageman has made strides in understanding the genetic factors associated with AMD.

Latest Patents

Hageman's latest patents include groundbreaking methods and reagents for the treatment of age-related macular degeneration. One of his inventions relates to Factor H gene polymorphisms and haplotypes that are associated with either an elevated or reduced risk of AMD. This invention provides essential methods and reagents for the diagnosis and treatment of AMD. Another significant patent involves methods for identifying subjects at risk for developing AMD, which includes kits that can be utilized to practice these methods. These methods focus on identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material, including polymorphisms in the BF, C2, and/or CFH genes. Additionally, microarrays and kits for use in these methods are also provided.

Career Highlights

Throughout his career, Hageman has worked with esteemed institutions such as the University of Iowa Research Foundation and Columbia University. His work has been pivotal in advancing the understanding of genetic predispositions to AMD, thereby contributing to potential therapeutic strategies.

Collaborations

Hageman has collaborated with notable colleagues, including Robert F Mullins and Rando L Allikmets, further enhancing the impact of his research in the field of ophthalmology.

Conclusion

Gregory S Hageman's innovative work in the realm of age-related macular degeneration has not only led to numerous patents but has also paved the way for future research and treatment options. His contributions continue to influence the medical community and improve patient outcomes.